Open user controls
- Log In Using Your Account
  Log In
  
  Don't have an account? Sign Up Today

- My Account
- Dashboard
- Profile
- Saved items
- Logout

78°
- Benton, AR (72018)
  Today
  
  Thunderstorms likely. High 81F. Winds SSW at 10 to 15 mph. Chance of rain 80%..
  
  Tonight
  
  Partly cloudy skies early will give way to cloudy skies late. Low near 65F. Winds SSW at 5 to 10 mph.
  
  Updated: April 13, 2026 @ 1:26 pm
- Full Forecast

- Site search

Home
News
- Local News
Sports
Obituaries
Multimedia
- Photo Galleries
- Videos
e-Edition
Classifieds
Archives
Readers Choice 2026
Community Calendar

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

NeoGenomics, Inc. - Common Stock (NQ:NEO)

7.970 +0.280 (+3.64%)

Streaming Delayed Price Updated: 3:09 PM EDT, Apr 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about NeoGenomics, Inc. - Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

NeoGenomics appoints Dr. Shashi Kulkarni, a World-Renowned Oncology Genomics Expert, and Innovator as Chief Scientific Officer

February 14, 2022

FT. MYERS, FL / ACCESSWIRE / February 14, 2022 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, has...

From NeoGenomics, Inc.

Via AccessWire

NeoGenomics Liquid Biopsy Subsidiary Inivata and Collaborators Publish Positive Results from Prospective Clinical Study of RaDaR(TM) in Head and Neck Squamous Cell Carcinoma

February 11, 2022

RaDaR demonstrated 100% specificity in patients with no recurrence and 100% sensitivity in patients with clinical recurrence FT MYERS, FL / ACCESSWIRE / February 11, 2022 / NeoGenomics, Inc....

From NeoGenomics, Inc.

Via AccessWire

NeoGenomics to Participate Virtually in Multiple Upcoming Institutional Investor Conferences

February 08, 2022

FT. MYERS, FL / ACCESSWIRE / February 8, 2022 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today...

From NeoGenomics, Inc.

Via AccessWire

NeoGenomics Schedules its Fourth Quarter and Full Year 2021 Earnings Release for February 23, 2022

February 02, 2022

FT MYERS, FL / ACCESSWIRE / February 2, 2022 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing and global contract research services, announced today that it plans...

From NeoGenomics, Inc.

Via AccessWire

Where NeoGenomics Stands With Analysts ↗

January 12, 2022

Over the past 3 months, 6 analysts have published their opinion on NeoGenomics (NASDAQ:

Via Benzinga

Analyst Ratings For NeoGenomics ↗

December 07, 2021

Within the last quarter, NeoGenomics (NASDAQ:NEO) has observed the following...

Via Benzinga

NeoGenomics First to Partner with Biomarker Collaborative and Deliver Patient Resources Along with Oncology Testing Results

January 24, 2022

The partnership makes it possible for patients with specific biomarkers to get early support FT. MYERS, FL / ACCESSWIRE / January 24, 2022 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of...

From NeoGenomics, Inc.

Via AccessWire

NeoGenomics Announces RaDaR(TM) Assay Receives CE Mark and is Submitted for US Reimbursement via the MolDX Program

January 11, 2022

FT. MYERS, FL / ACCESSWIRE / January 11, 2022 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today...

From NeoGenomics, Inc.

Via AccessWire

New Developments in Fight Against Blood Cancers, in Leadup to US$17.1 Billion Market by 2024

January 10, 2022

FN Media Group Presents USA News Group News Commentary Vancouver, BC –January 10, 2021 – USA News Group – Nearly 10% of the estimated ~1.9 million new cancer cases in the USA will be diagnosed as...

Via FinancialNewsMedia

Where NeoGenomics Stands With Analysts ↗

November 05, 2021

Over the past 3 months, 4 analysts have published their opinion on NeoGenomics (NASDAQ:

Via Benzinga

Recap: NeoGenomics Q3 Earnings ↗

November 04, 2021

NeoGenomics (NASDAQ:NEO) reported its Q3 earnings results on Thursday, November 4, 2021 at 08:00 AM. Here's what investors need to know about the announcement. Earnings...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

December 28, 2021

Gainers China SXT Pharmaceuticals (NASDAQ:SXT...

Via Benzinga

NeoGenomics Appoints David Eberhard MD, PhD as Chief Medical Officer of Inivata Liquid Biopsy Subsidiary

December 13, 2021

FT MYERS, FL / ACCESSWIRE / December 13, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today...

From NeoGenomics, Inc.

Via AccessWire

Topics Regulatory Compliance

NeoGenomics to Leverage Thermo Fisher Scientific’s Ion Torrent Genexus System in Upcoming Phase 1 Study for Myeloid Cancers

December 10, 2021

FT. MYERS, FL / ACCESSWIRE / December 10, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, announced...

From NeoGenomics, Inc.

Via AccessWire

Topics Regulatory Compliance

Benzinga's Top Ratings Upgrades, Downgrades For December 16, 2021 ↗

December 16, 2021

Upgrades According to B of A Securities, the prior rating for Generac Holdings Inc (NYSE:

Via Benzinga

The Implications Behind Genetron Health's Latest Earnings Report ↗

December 08, 2021

Genetron Holdings Limited (NASDAQ: GTH) recently announced its latest fiscal report, elaborating its progress in the oncology genetic testing industry. The China-based company provides early tumor...

Via Talk Markets

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

December 07, 2021

Gainers PLx Pharma (NASDAQ:PLXP) stock in...

Via Benzinga

The Implications Behind Genetron Health's Latest Earnings Report ↗

December 03, 2021

Image provided by Mentor Finance Genetron Holdings Limited (NASDAQ: GTH) recently announced its latest fiscal report, elaborating its progress in the oncology genetic testing...

Via Benzinga

NeoGenomics To Participate In The Stephens Annual Investment Conference 2021

November 30, 2021

FT. MYERS, FL / ACCESSWIRE / November 30, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today...

From NeoGenomics, Inc.

Via AccessWire

Topics Regulatory Compliance

NASDAQ: NEO Shareholder Notice: Investigation over Potential Wrongdoing at NeoGenomics, Inc. ↗

November 29, 2021

San Diego, CA -- (SBWIRE) -- 11/29/2021 -- An investigation on behalf of investors in NeoGenomics, Inc. (NASDAQ: NEO) shares over potential wrongdoing at NeoGenomics, Inc. was announced.

Via SBWire

NASDAQ:NEO Investor Notice: Investigation over Possible Securities Laws Violations by NeoGenomics, Inc. ↗

November 10, 2021

San Diego, CA -- (SBWIRE) -- 11/10/2021 -- NeoGenomics, Inc. is under investigation concerning possible violations of securities laws in connection with certain financial statements.

Via SBWire

NeoGenomics Appoints Dave Daly to Its Board of Directors

November 10, 2021

FT. MYERS, FL / ACCESSWIRE / November 10, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, has...

From NeoGenomics, Inc.

Via AccessWire

Topics Regulatory Compliance

NeoGenomics, inc (NEO) Q3 2021 Earnings Call Transcript ↗

November 06, 2021

NEO earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

NeoGenomics Reports Revenue of $121 Million in the Third Quarter

November 04, 2021

Third-Quarter 2021 Results and Highlights: - Consolidated revenue of $121 million, comprised of Clinical Services revenue of $102 million and Pharma Services revenue of $19 million - Consolidated...

From NeoGenomics, Inc.

Via AccessWire

Topics Regulatory Compliance Retirement

81 Biggest Movers From Yesterday ↗

November 05, 2021

Gainers Evaxion Biotech A/S (NASDAQ: EVAX) shares jumped 95.1% to close at $12.68 on Thursday after dropping over 10% on Wednesday. TDH Holdings, Inc. (NASDAQ: PETZ) jumped 79.8...

Via Benzinga

55 Stocks Moving In Thursday's Mid-Day Session ↗

November 04, 2021

Gainers Evaxion Biotech A/S (NASDAQ: EVAX) shares climbed 179% to $18.17 after dropping over 10% on Wednesday. NerdWallet, Inc. (NASDAQ: NRDS) jumped 60% to $28.86 after the...

Via Benzinga

NeoGenomics Announces Leadership Team Transition

November 04, 2021

FT. MYERS, FL / ACCESSWIRE / November 4, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, announced...

From NeoGenomics, Inc.

Via AccessWire

Topics Regulatory Compliance

The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO ↗

November 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &...

Via Benzinga

NeoGenomics' Liquid Biopsy Subsidiary Inivata Announces Clinical Collaboration With Princess Margaret Cancer Center for the Use of Its Liquid Biopsy Assays

October 19, 2021

Two clinical studies including interventional RaDaR™ study FT. MYERS, FL / ACCESSWIRE / October 19, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services...

From NeoGenomics, Inc.

Via AccessWire

Topics Regulatory Compliance

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline ↗

October 31, 2021

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...

Via Benzinga

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Entertainment
Local Events
Obituaries
Multimedia
Announcements
e-Edition
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

bentoncourier.com
321 North Market Street
Benton, AR 72018
Phone: 501-315-8228
Email: bcadmin@bentoncourier.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Log In Using Your Account

Benton, AR (72018)

Today

Tonight

NeoGenomics, Inc. - Common Stock (NQ:NEO)

All News about NeoGenomics, Inc. - Common Stock

Sections

Services

Follow Us